URSO, ANTONIO
URSO, ANTONIO
Dipartimento di Scienze mediche
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness
file con accesso da definire2017 Rigolin, Gian Matteo; Formigaro, Luca; Cavallari, Maurizio; Quaglia, Francesca Maria; Lista, E; Urso, Antonio; Guardalben, Emanuele; Martinelli, Sara; Saccenti, Elena; Bassi, Cristian; Lupini, Laura; Bardi, Maria Antonella; Volta, Eleonora; Tammiso, Elisa; Melandri, A; Negrini, Massimo; Cavazzini, Francesco; Cuneo, Antonio
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness
file con accesso da definire2017 Rigolin, Gian Matteo; Formigaro, Luca; Cavallari, Maurizio; Quaglia, Francesca Maria; Lista, Enrico; Urso, Antonio; Guardalben, Emanuele; Martinelli, Sara; Saccenti, Elena; Bassi, Cristian; Lupini, Laura; Bardi, Maria Antonella; Volta, Eleonora; Tammiso, Elisa; Melandri, Aurora; Negrini, Massimo; Cavazzini, Francesco; Cuneo, Antonio
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia
2018 Cavallari, Maurizio; Cavazzini, Francesco; Antonella, Bardi; Volta, Eleonora; Melandri, Aurora; Tammiso, Elisa; Saccenti, Elena; Lista, Enrico; Quaglia, Francesca Maria; Urso, Antonio; Laudisi, Michele; Menotti, Elisa; Luca, Formigaro; Melissa, Dabusti; Maria, Ciccone; Paolo, Tomasi; Negrini, Massimo; Cuneo, Antonio; Rigolin, Gian Matteo
Chronic Lymphocytic Leukemia: Prognostic Factors in the Era of Novel Drugs
file con accesso da definire2024 Urso, Antonio; Martino, Enrica Antonia; Cuneo, Antonio; Gentile, Massimo; Rigolin, Gian Matteo
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z)
file con accesso da definire2016 Rigolin, Gian Matteo; Saccenti, Elena; Bassi, Cristian; Lupini, Laura; Quaglia, Francesca Maria; Cavallari, Maurizio; Martinelli, Sara; Formigaro, Luca; Lista, Enrico; Bardi, Maria Antonella; Volta, Eleonora; Tammiso, Elisa; Melandri, Aurora; Urso, Antonio; Cavazzini, Francesco; Negrini, Massimo; Cuneo, Antonio
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations
file con accesso da definire2016 Rigolin, Gian Matteo; Saccenti, Elena; Bassi, Cristian; Lupini, Laura; Quaglia, Francesca Maria; Cavallari, Maurizio; Martinelli, Sara; Formigaro, Luca; Lista, Enrico; Bardi, Maria Antonella; Volta, Eleonora; Tammiso, Elisa; Melandri, Aurora; Urso, Antonio; Cavazzini, Francesco; Negrini, Massimo; Cuneo, Antonio
First-Line Treatment of Older Patients with CLL: A New Approach in the Chemo-Free Era
2023 Urso, Antonio; Cavazzini, Francesco; Ballardini, Maria Pia; Gambara, Silvia; Consolo, Sara; Rigolin, Gian Matteo; Cuneo, Antonio
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics
2018 Rigolin, Gian Matteo; Saccenti, Elena; Guardalben, Emanuele; Cavallari, Maurizio; Formigaro, Luca; Zagatti, Barbara; Visentin, Andrea; Mauro, Francesca R.; Lista, Enrico; Bassi, Cristian; Lupini, Laura; Quaglia, Francesca Maria; Urso, Antonio; Bardi, Maria Antonella; Bonaldi, Laura; Volta, Eleonora; Tammiso, Elisa; Ilari, Caterina; Cafforio, Luciana; Melandri, Aurora; Cavazzini, Francesco; Negrini, Massimo; Semenzato, Gianpietro; Trentin, Livio; Foà, Robin; Cuneo, Antonio
In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome
2021 Rigolin, G. M.; Saccenti, E.; Melandri, A.; Cavallari, M.; Urso, A.; Rotondo, F.; Betulla, A.; Tognolo, L.; Bardi, M. A.; Rossini, M.; Tammiso, E.; Bassi, C.; Cavazzini, F.; Negrini, M.; Cuneo, A.
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI
2017 Rigolin, Gian Matteo; Cavallari, Maurizio; Quaglia, Francesca Maria; Formigaro, Luca; Lista, Enrico; Urso, Antonio; Guardalben, Emanuele; Liberatore, Carmine; Faraci, Danilo; Saccenti, Elena; Bassi, Cristian; Lupini, Laura; Bardi, Maria Antonella; Volta, Eleonora; Tammiso, Elisa; Melandri, Aurora; Negrini, Massimo; Cavazzini, Francesco; Cuneo, Antonio
Outcomes and prognostic factors in 3306 patients with relapsed/refractory chronic lymphocytic leukemia treated with ibrutinib outside of clinical trials: A nationwide study
file con accesso da definire2024 Rigolin, Gian Matteo; Olimpieri, Pier Paolo; Summa, Valentina; Celant, Simone; Scarfò, Lydia; Ballardini, Maria Pia; Urso, Antonio; Gambara, Silvia; Cavazzini, Francesco; Ghia, Paolo; Cuneo, Antonio; Russo, Pierluigi
Outcomes in patients with chronic lymphocytic leukemia and TP53 aberration who received first-line ibrutinib: a nationwide registry study from the Italian Medicines Agency
2023 Rigolin, Gian Matteo; Olimpieri, Pier Paolo; Summa, Valentina; Celant, Simone; Scarfò, Lydia; Tognolo, Lucia; Ballardini, Maria Pia; Urso, Antonio; Sessa, Mariarosaria; Gambara, Silvia; Cura, Francesca; Fortini, Monica; Ghia, Paolo; Cuneo, Antonio; Russo, Pierluigi
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation
2019 Quaglia, F. M.; Rigolin, G. M.; Saccenti, E.; Negrini, M.; Volta, E.; Dabusti, M.; Ciccone, M.; Urso, A.; Laudisi, M.; Cuneo, A.
Spontaneously reversible adrenal nodules in primary diffuse large B-cell testicular lymphoma mimicking an extranodal involvement: A case report
2021 Pellegrino, F.; Scabbia, F.; Merlo, A.; Perrucci, L.; Aliberti, L.; Urso, A.; Ambrosio, M. R.; Cuneo, A.; Galeotti, R.; Giganti, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness | 2017 | Rigolin, Gian Matteo; Formigaro, Luca; Cavallari, Maurizio; Quaglia, Francesca Maria; Lista, E; U...rso, Antonio; Guardalben, Emanuele; Martinelli, Sara; Saccenti, Elena; Bassi, Cristian; Lupini, Laura; Bardi, Maria Antonella; Volta, Eleonora; Tammiso, Elisa; Melandri, A; Negrini, Massimo; Cavazzini, Francesco; Cuneo, Antonio | file con accesso da definire |
| An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness | 2017 | Rigolin, Gian Matteo; Formigaro, Luca; Cavallari, Maurizio; Quaglia, Francesca Maria; Lista, Enri...co; Urso, Antonio; Guardalben, Emanuele; Martinelli, Sara; Saccenti, Elena; Bassi, Cristian; Lupini, Laura; Bardi, Maria Antonella; Volta, Eleonora; Tammiso, Elisa; Melandri, Aurora; Negrini, Massimo; Cavazzini, Francesco; Cuneo, Antonio | file con accesso da definire |
| Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia | 2018 | Cavallari, Maurizio; Cavazzini, Francesco; Antonella, Bardi; Volta, Eleonora; Melandri, Aurora; T...ammiso, Elisa; Saccenti, Elena; Lista, Enrico; Quaglia, Francesca Maria; Urso, Antonio; Laudisi, Michele; Menotti, Elisa; Luca, Formigaro; Melissa, Dabusti; Maria, Ciccone; Paolo, Tomasi; Negrini, Massimo; Cuneo, Antonio; Rigolin, Gian Matteo | |
| Chronic Lymphocytic Leukemia: Prognostic Factors in the Era of Novel Drugs | 2024 | Urso, Antonio; Martino, Enrica Antonia; Cuneo, Antonio; Gentile, Massimo; Rigolin, Gian Matteo | file con accesso da definire |
| Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) | 2016 | Rigolin, Gian Matteo; Saccenti, Elena; Bassi, Cristian; Lupini, Laura; Quaglia, Francesca Maria; ...Cavallari, Maurizio; Martinelli, Sara; Formigaro, Luca; Lista, Enrico; Bardi, Maria Antonella; Volta, Eleonora; Tammiso, Elisa; Melandri, Aurora; Urso, Antonio; Cavazzini, Francesco; Negrini, Massimo; Cuneo, Antonio | file con accesso da definire |
| Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations | 2016 | Rigolin, Gian Matteo; Saccenti, Elena; Bassi, Cristian; Lupini, Laura; Quaglia, Francesca Maria; ...Cavallari, Maurizio; Martinelli, Sara; Formigaro, Luca; Lista, Enrico; Bardi, Maria Antonella; Volta, Eleonora; Tammiso, Elisa; Melandri, Aurora; Urso, Antonio; Cavazzini, Francesco; Negrini, Massimo; Cuneo, Antonio | file con accesso da definire |
| First-Line Treatment of Older Patients with CLL: A New Approach in the Chemo-Free Era | 2023 | Urso, Antonio; Cavazzini, Francesco; Ballardini, Maria Pia; Gambara, Silvia; Consolo, Sara; Rigol...in, Gian Matteo; Cuneo, Antonio | |
| In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics | 2018 | Rigolin, Gian Matteo; Saccenti, Elena; Guardalben, Emanuele; Cavallari, Maurizio; Formigaro, Luca...; Zagatti, Barbara; Visentin, Andrea; Mauro, Francesca R.; Lista, Enrico; Bassi, Cristian; Lupini, Laura; Quaglia, Francesca Maria; Urso, Antonio; Bardi, Maria Antonella; Bonaldi, Laura; Volta, Eleonora; Tammiso, Elisa; Ilari, Caterina; Cafforio, Luciana; Melandri, Aurora; Cavazzini, Francesco; Negrini, Massimo; Semenzato, Gianpietro; Trentin, Livio; Foà, Robin; Cuneo, Antonio | |
| In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome | 2021 | Rigolin, G. M.; Saccenti, E.; Melandri, A.; Cavallari, M.; Urso, A.; Rotondo, F.; Betulla, A.; To...gnolo, L.; Bardi, M. A.; Rossini, M.; Tammiso, E.; Bassi, C.; Cavazzini, F.; Negrini, M.; Cuneo, A. | |
| In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI | 2017 | Rigolin, Gian Matteo; Cavallari, Maurizio; Quaglia, Francesca Maria; Formigaro, Luca; Lista, Enri...co; Urso, Antonio; Guardalben, Emanuele; Liberatore, Carmine; Faraci, Danilo; Saccenti, Elena; Bassi, Cristian; Lupini, Laura; Bardi, Maria Antonella; Volta, Eleonora; Tammiso, Elisa; Melandri, Aurora; Negrini, Massimo; Cavazzini, Francesco; Cuneo, Antonio | |
| Outcomes and prognostic factors in 3306 patients with relapsed/refractory chronic lymphocytic leukemia treated with ibrutinib outside of clinical trials: A nationwide study | 2024 | Rigolin, Gian Matteo; Olimpieri, Pier Paolo; Summa, Valentina; Celant, Simone; Scarfò, Lydia; Bal...lardini, Maria Pia; Urso, Antonio; Gambara, Silvia; Cavazzini, Francesco; Ghia, Paolo; Cuneo, Antonio; Russo, Pierluigi | file con accesso da definire |
| Outcomes in patients with chronic lymphocytic leukemia and TP53 aberration who received first-line ibrutinib: a nationwide registry study from the Italian Medicines Agency | 2023 | Rigolin, Gian Matteo; Olimpieri, Pier Paolo; Summa, Valentina; Celant, Simone; Scarfò, Lydia; Tog...nolo, Lucia; Ballardini, Maria Pia; Urso, Antonio; Sessa, Mariarosaria; Gambara, Silvia; Cura, Francesca; Fortini, Monica; Ghia, Paolo; Cuneo, Antonio; Russo, Pierluigi | |
| Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation | 2019 | Quaglia, F. M.; Rigolin, G. M.; Saccenti, E.; Negrini, M.; Volta, E.; Dabusti, M.; Ciccone, M.; U...rso, A.; Laudisi, M.; Cuneo, A. | |
| Spontaneously reversible adrenal nodules in primary diffuse large B-cell testicular lymphoma mimicking an extranodal involvement: A case report | 2021 | Pellegrino, F.; Scabbia, F.; Merlo, A.; Perrucci, L.; Aliberti, L.; Urso, A.; Ambrosio, M. R.; Cu...neo, A.; Galeotti, R.; Giganti, M. |